AKBA AKEBIA THERAPEUTICS INC
Permanent stock page ↗Health Care · Russell 2000
Next earnings: Mon 9 Nov 2026 · during market hours
What 8 analyst firms say about AKEBIA THERAPEUTICS INC: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
7 rated views · 8 analyst/firm records · 8 firms
Radar score
- Russell 2000 · Top Picks · 6MNot scored · Price below 5 USD
- Russell 2000 · Safest consensus · 6MNot scored · Price below 5 USD
Recent analyst activity · last 90 days
Our tracked history has 4 reports on AKBA from 4 analyst firms in the last 90 days (8 firms in the past year).
Comparing each firm's latest target with its previous one: 2 left it unchanged and 1 has its first observed target in the past year.
No firm's latest available rating differs from its previous one.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| BTIG | Julian Harrison | Buy | 15 Sep 2026 | 4.00 USD |
| H.C. Wainwright | Matthew Caufield | Buy | 6 Aug 2026 | 6.00 USD · 8 May 2026 |
| Jefferies | Roger Song | Buy | 8 May 2026 | 4.00 USD |
| Leerink Partners | Roanna Ruiz | Hold | 7 Aug 2026 | 1.00 USD |
| Piper Sandler | Allison M Bratzel | Buy | 17 Aug 2026 | 4.00 USD |
| Weiss Ratings | Unnamed analyst | — | 2 Oct 2026 | — |
| Westpark Capital | Ed Arce | Buy | 8 Sep 2026 | 4.50 USD |
| Data feed RESEARCH | Research Team | Hold | 7 Jul 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 03:37 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.